Ligand Pharmaceuticals
LGND
#3601
Rank
A$5.47 B
Marketcap
A$278.32
Share price
-1.93%
Change (1 day)
45.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of September 2025 : A$1.01 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has A$1.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.41 B64.75%
2023-12-31A$0.24 B-19.71%
2022-12-31A$0.31 B-33.83%
2021-12-31A$0.47 B-12.01%
2020-12-31A$0.53 B-65%
2019-12-31A$1.52 B39.11%
2018-12-31A$1.09 B325.25%
2017-12-31A$0.25 B32.01%
2016-12-31A$0.19 B-28.8%
2015-12-31A$0.27 B34.42%
2014-12-31A$0.20 B1041.38%
2013-12-31A$17.91 M50.36%
2012-12-31A$11.91 M-28.31%
2011-12-31A$16.61 M-25.62%
2010-12-31A$22.34 M-62.29%
2009-12-31A$59.25 M-48.18%
2008-12-31A$0.11 B5.89%
2007-12-31A$0.10 B-50.47%
2006-12-31A$0.21 B83.49%
2005-12-31A$0.11 B-18.27%
2004-12-31A$0.14 B9.1%
2003-12-31A$0.13 B16.84%
2002-12-31A$0.11 B54.42%
2001-12-31A$73.84 M74.49%
2000-12-31A$42.32 M-41.08%
1999-12-31A$71.82 M34.09%
1998-12-31A$53.56 M-43.98%
1997-12-31A$95.62 M118.29%
1996-12-31A$43.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
A$14.21 B 1,295.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$84.51 M-91.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$6.69 B 556.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$27.42 B 2,590.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$22.55 B 2,113.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$14.92 B 1,364.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$24.84 B 2,337.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$2.59 B 154.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.94 B 2,642.05%๐Ÿ‡บ๐Ÿ‡ธ USA